Dual methylation and hydroxymethylation study of alcohol use disorder. (17th November 2021)

• Record Type: Journal Article
• Authors: Clark, Shaunna L.; Chan, Robin F.; Zhao, Min; Xie, Lin Y.; Copeland, William E.; Penninx, Brenda W. J. H.; Aberg, Karolina A.; van den Oord, Edwin J. C. G.
• Is Part Of: Addiction biology. Volume 27:Number 2(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-11-17
• Subjects: alcohol use disorder -- hydroxymethylation -- methylation; Substance abuse -- Periodicals; Substance abuse -- Physiological aspects -- Periodicals; Substance-Related Disorders -- periodicals; 616.86
• DOI: 10.1111/adb.13114
• Languages: English
• ISSNs: 1355-6215

Abstract

Abstract: Using an integrative, multi‐tissue design, we sought to characterize methylation and hydroxymethylation changes in blood and brain associated with alcohol use disorder (AUD). First, we used epigenomic deconvolution to perform cell‐type‐specific methylome‐wide association studies within subpopulations of granulocytes/T‐cells/B‐cells/monocytes in 1132 blood samples. Blood findings were then examined for overlap with AUD‐related associations with methylation and hydroxymethylation in 50 human post‐mortem brain samples. Follow‐up analyses investigated if overlapping findings mediated AUD‐associated transcription changes in the same brain samples. Lastly, we replicated our blood findings in an independent sample of 412 individuals and aimed to replicate published alcohol methylation findings using our results. Cell‐type‐specific analyses in blood identified methylome‐wide significant associations in monocytes and T‐cells. The monocyte findings were significantly enriched for AUD‐related methylation and hydroxymethylation in brain. Hydroxymethylation in specific sites mediated AUD‐associated transcription in the same brain samples. As part of the most comprehensive methylation study of AUD to date, this work involved the first cell‐type‐specific methylation study of AUD conducted in blood, identifying and replicating a finding in DLGAP1 that may be a blood‐based biomarker of AUD. In this first study to consider the role of hydroxymethylation in AUD, we found evidence for a novel mechanism for cognitive deficits associated with AUD. Our results suggest promising new avenues for AUD research. Abstract : Using an integrative, multi‐tissue design, we sought to characterize methylation and hydroxymethylation changes in blood and brain associated with alcohol use disorder (AUD). This work involved the first cell‐type‐specific methylation study of AUD conducted in blood, identifying and replicating a site in DLGAP1 that may be involved in AUD‐related brain impairment. In this first study to consider the role of hydroxymethylation in AUD, we found evidence for a novel mechanism for cognitive deficits associated with AUD.